[ad_1] FDA Approves Asthma Indication For Dupixent® (Dupilumab) Only approved biologics for moderate and severe asthmatic patients with eosinophilic phenotype Only biological product approved for oral asthma dependent on corticosteroids, no matter …
Read More »